Gene expression in CD34(+) cells from normal bone marrow and leukemic origins.

INTRODUCTION To address the molecular regulation of hematopoiesis and the complex mechanism in leukemogenesis, we established the first catalogs of genes expressed in normal bone marrow and leukemia CD34(+) cells. MATERIALS AND METHODS CD34(+) cell cDNA libraries were constructed using mRNA from adult bone marrow and from a case of acute myeloid leukemia-M5 transformed from myelodysplastic syndrome (MDS-AML). Expressed sequence tags (ESTs) and full-length cDNAs were generated by sequencing and were annotated using bioinformatic tools. RESULTS From a total of 4142 ESTs obtained from normal bone marrow, 3424 meaningful tags were integrated into 1630 clusters, representing 622 known genes, 522 dbEST entries and 486 novel sequences. Out of 5382 ESTs from MDS-AML, 1985 clusters were produced based on the analysis of 4321 useful ESTs, including 711 known genes, 657 known ESTs and 617 novel sequences. Among 251 transcripts found in both bone marrow and MDS-AML EST datasets and those present in only one dataset, 58 showed statistically significant differences in EST copy numbers between the two tissues (P<0.05). Twenty putative full-length cDNAs for novel genes were also cloned from the MDS-AML library. CONCLUSION The distinct gene expression patterns in MDS-AML-CD34(+) cells as compared to normal control cells may contribute to the development and/or maintenance of the malignant phenotypes of leukemia cells.

[1]  C. Stournaras,et al.  Altered actin polymerization dynamics in various malignant cell types: evidence for differential sensitivity to cytochalasin B. , 1996, Biochemical pharmacology.

[2]  I. Weissman,et al.  Hematopoietic stem cells: challenges to expectations. , 1997, Current opinion in immunology.

[3]  C. Shih,et al.  Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. , 1999, Blood.

[4]  E. Nishida,et al.  Molecular Cloning and Characterization of a Novel Dual Specificity Phosphatase, MKP-5* , 1999, The Journal of Biological Chemistry.

[5]  I. Weissman,et al.  The biology of hematopoietic stem cells. , 1995, Annual review of cell and developmental biology.

[6]  G. Nabel,et al.  Isolation of a cDNA clone encoding a zinc finger protein highly expressed in T-leukemia lines. , 1992, Blood.

[7]  G. Crooks,et al.  A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. , 1995, Blood.

[8]  G. Fu,et al.  Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Claverie,et al.  The significance of digital gene expression profiles. , 1997, Genome research.

[10]  M. Sanz,et al.  Etiopathogeny, prognosis and therapy of myelodysplastic syndromes. , 1997, Hematology and cell therapy.

[11]  K. Hirokawa,et al.  Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes , 1997, Leukemia.

[12]  M. Ogawa,et al.  Reversible expression of CD34 by murine hematopoietic stem cells. , 1999, Blood.

[13]  R. Bhatia,et al.  Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors. , 1999, Experimental hematology.

[14]  T. Yin,et al.  Interleukin (IL)‐11‐mediated Signal Transduction a , 1995, Annals of the New York Academy of Sciences.

[15]  J. Wagner,et al.  Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application. , 1995, Haematologica.